Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$81.84 -2.08 (-2.48%)
As of: Oct 2, 2026 · 2:32 PM EDT

Mirum Pharmaceuticals (MIRM) Return on Assets [ROA] (2019 - 2026)

Updated

Mirum Pharmaceuticals' Return on Assets [ROA] was -88.87% in Q2 2026, down 80.60 percentage points from -8.27% a year earlier but up 3.28 percentage points from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Return on Assets [ROA] (2019 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Mirum Pharmaceuticals came in at -3.09%, up 10.26 percentage points from FY2024.

  • Return on Assets [ROA] has now increased for three consecutive years, with a five-year change of +50.20 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -13.35% in FY2024 (+19.35 pp), -32.70% in FY2023 (+9.20 pp), -41.90% in FY2022 (-10.53 pp) and -31.37% in FY2021 (+21.92 pp).
  • Quarterly Return on Assets [ROA] has moved between -92.15% (Q1 2026) and -2.87% (Q4 2025) over five years.
  • Compared with a year earlier, Return on Assets [ROA] was higher in six of the last eight quarters, with an average year-over-year change of -11.64 percentage points.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2022 (a gain of 61.43 percentage points); the worst was Q1 2026 (a drop of 80.79 percentage points).
  • Per Business Quant data, MIRM's Return on Assets [ROA] in the three quarters before Q2 2026 was -92.15% (Q1 2026), -2.87% (Q4 2025) and -5.48% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Mirum Pharmaceuticals 5.54 Bn 3.95 Bn 145.90 Mn -88.87%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -88.87%
Mar 31, 2026 -92.15%
Dec 31, 2025 -2.87%
Sep 30, 2025 -5.48%
Jun 30, 2025 -8.27%
Mar 31, 2025 -11.37%
Dec 31, 2024 -13.14%
Sep 30, 2024 -15.02%
Jun 30, 2024 -16.63%
Mar 31, 2024 -24.42%
Dec 31, 2023 -25.19%
Sep 30, 2023 -30.01%
Jun 30, 2023 -45.37%
Mar 31, 2023 -37.64%
Dec 31, 2022 -37.83%
Sep 30, 2022 -12.60%
Jun 30, 2022 -18.45%
Mar 31, 2022 -24.46%
Dec 31, 2021 -31.70%
Sep 30, 2021 -74.04%
API Access

Mirum Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MIRM&period=max&api_key=YOUR_API_KEY